139 related articles for article (PubMed ID: 3121480)
1. Metabolism of estragole in rat and mouse and influence of dose size on excretion of the proximate carcinogen 1'-hydroxyestragole.
Anthony A; Caldwell J; Hutt AJ; Smith RL
Food Chem Toxicol; 1987 Nov; 25(11):799-806. PubMed ID: 3121480
[TBL] [Abstract][Full Text] [Related]
2. A physiologically based biokinetic (PBBK) model for estragole bioactivation and detoxification in rat.
Punt A; Freidig AP; Delatour T; Scholz G; Boersma MG; Schilter B; van Bladeren PJ; Rietjens IM
Toxicol Appl Pharmacol; 2008 Sep; 231(2):248-59. PubMed ID: 18539307
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of human interindividual variation in bioactivation of estragole using physiologically based biokinetic modeling.
Punt A; Jeurissen SM; Boersma MG; Delatour T; Scholz G; Schilter B; van Bladeren PJ; Rietjens IM
Toxicol Sci; 2010 Feb; 113(2):337-48. PubMed ID: 19920071
[TBL] [Abstract][Full Text] [Related]
4. The side-chain epoxidation and hydroxylation of the hepatocarcinogens safrole and estragole and some related compounds by rat and mouse liver microsomes.
Swanson AB; Miller EC; Miller JA
Biochim Biophys Acta; 1981 Apr; 673(4):504-16. PubMed ID: 7225430
[TBL] [Abstract][Full Text] [Related]
5. Human cytochrome p450 enzyme specificity for the bioactivation of estragole and related alkenylbenzenes.
Jeurissen SM; Punt A; Boersma MG; Bogaards JJ; Fiamegos YC; Schilter B; van Bladeren PJ; Cnubben NH; Rietjens IM
Chem Res Toxicol; 2007 May; 20(5):798-806. PubMed ID: 17407329
[TBL] [Abstract][Full Text] [Related]
6. The metabolism of p-propylanisole in the rat and mouse and its variation with dose.
Sangster SA; Caldwell J; Hutt AJ; Smith RL
Food Chem Toxicol; 1983 Jun; 21(3):263-71. PubMed ID: 6683223
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of anethole. I. Pathways of metabolism in the rat and mouse.
Sangster SA; Caldwell J; Smith RL; Farmer PB
Food Chem Toxicol; 1984 Sep; 22(9):695-706. PubMed ID: 6541622
[TBL] [Abstract][Full Text] [Related]
8. Hepatocarcinogenicity of estragole (1-allyl-4-methoxybenzene) and 1'-hydroxyestragole in the mouse and mutagenicity of 1'-acetoxyestragole in bacteria.
Drinkwater NR; Miller EC; Miller JA; Pitot HC
J Natl Cancer Inst; 1976 Dec; 57(6):1323-31. PubMed ID: 187802
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of anethole. II. Influence of dose size on the route of metabolism of trans-anethole in the rat and mouse.
Sangster SA; Caldwell J; Smith RL
Food Chem Toxicol; 1984 Sep; 22(9):707-13. PubMed ID: 6541623
[TBL] [Abstract][Full Text] [Related]
10. Immunochemical identification of hepatic protein adducts derived from estragole.
Wakazono H; Gardner I; Eliasson E; Coughtrie MW; Kenna JG; Caldwell J
Chem Res Toxicol; 1998 Aug; 11(8):863-72. PubMed ID: 9705747
[TBL] [Abstract][Full Text] [Related]
11. Use of physiologically based biokinetic (PBBK) modeling to study estragole bioactivation and detoxification in humans as compared with male rats.
Punt A; Paini A; Boersma MG; Freidig AP; Delatour T; Scholz G; Schilter B; van Bladeren PJ; Rietjens IM
Toxicol Sci; 2009 Aug; 110(2):255-69. PubMed ID: 19447879
[TBL] [Abstract][Full Text] [Related]
12. Dose dependent conversion of estragole in the rat and mouse to the carcinogenic metabolite, 1'-hydroxyestragole.
Zangouras A; Caldwell J; Hutt AJ; Smith RL
Biochem Pharmacol; 1981 Jun; 30(11):1383-6. PubMed ID: 7271835
[No Abstract] [Full Text] [Related]
13. Identification of nevadensin as an important herb-based constituent inhibiting estragole bioactivation and physiology-based biokinetic modeling of its possible in vivo effect.
Alhusainy W; Paini A; Punt A; Louisse J; Spenkelink A; Vervoort J; Delatour T; Scholz G; Schilter B; Adams T; van Bladeren PJ; Rietjens IM
Toxicol Appl Pharmacol; 2010 Jun; 245(2):179-90. PubMed ID: 20226806
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity studies of the carcinogenicities in the mouse and rat of some naturally occurring and synthetic alkenylbenzene derivatives related to safrole and estragole.
Miller EC; Swanson AB; Phillips DH; Fletcher TL; Liem A; Miller JA
Cancer Res; 1983 Mar; 43(3):1124-34. PubMed ID: 6825084
[TBL] [Abstract][Full Text] [Related]
15. Study of the metabolism of estragole in humans consuming fennel tea.
Zeller A; Horst K; Rychlik M
Chem Res Toxicol; 2009 Dec; 22(12):1929-37. PubMed ID: 19908891
[TBL] [Abstract][Full Text] [Related]
16. Comparative induction of unscheduled DNA synthesis in cultured rat hepatocytes by allylbenzenes and their 1'-hydroxy metabolites.
Chan VS; Caldwell J
Food Chem Toxicol; 1992 Oct; 30(10):831-6. PubMed ID: 1427504
[TBL] [Abstract][Full Text] [Related]
17. NTP 3-month toxicity studies of estragole (CAS No. 140-67-0) administered by gavage to F344/N rats and B6C3F1 mice.
Bristol DW
Toxic Rep Ser; 2011 Jan; (82):1-111. PubMed ID: 21445103
[TBL] [Abstract][Full Text] [Related]
18. In vivo validation of DNA adduct formation by estragole in rats predicted by physiologically based biodynamic modelling.
Paini A; Punt A; Scholz G; Gremaud E; Spenkelink B; Alink G; Schilter B; van Bladeren PJ; Rietjens IM
Mutagenesis; 2012 Nov; 27(6):653-63. PubMed ID: 22844077
[TBL] [Abstract][Full Text] [Related]
19. The metabolic disposition of [methoxy-14C]-labelled trans-anethole, estragole and p-propylanisole in human volunteers.
Sangster SA; Caldwell J; Hutt AJ; Anthony A; Smith RL
Xenobiotica; 1987 Oct; 17(10):1223-32. PubMed ID: 3424869
[TBL] [Abstract][Full Text] [Related]
20. Progenitor-derived hepatocyte-like (B-13/H) cells metabolise 1'-hydroxyestragole to a genotoxic species via a SULT2B1-dependent mechanism.
Probert PM; Palmer JM; Alhusainy W; Amer AO; Rietjens IM; White SA; Jones DE; Wright MC
Toxicol Lett; 2016 Jan; 243():98-110. PubMed ID: 26739637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
